Qiuying Cheng Selected Research

daunorubicinol

10/2016	Transcriptional regulation of the canine carbonyl reductase 1 gene (cbr1) by the specificity protein 1 (Sp1).
7/2015	Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiuying Cheng Research Topics

Disease

6	Malaria 06/2022 - 07/2019
6	Neoplasms (Cancer) 10/2016 - 09/2007
3	COVID-19 01/2022 - 01/2020
3	Anemia 01/2022 - 01/2020
3	Cardiotoxicity 10/2016 - 12/2010
2	Infections 03/2022 - 01/2020
1	Bacteremia 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2018
1	Lung Neoplasms (Lung Cancer) 06/2012
1	Body Weight (Weight, Body) 01/2012
1	Down Syndrome (Down's Syndrome) 12/2010

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 07/2019 - 06/2012
3	AnthracyclinesIBA 10/2016 - 12/2010
3	SurvivinIBA 01/2012 - 09/2007
2	hemozoinIBA 03/2022 - 07/2019
2	daunorubicinolIBA 10/2016 - 07/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 01/2012
2	Carbonyl Reductase (NADPH)IBA 06/2012 - 12/2010
1	insulin receptor-related receptor (IRR)IBA 06/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	artemisinin (artemisinine)IBA 10/2020
1	Neutralizing AntibodiesIBA 10/2020
1	Investigational DrugsIBA 10/2020
1	tyrosyl-tyrosyl-glutamyl-glutamic acidIBA 01/2020
1	2-thioxo-4-thiazolidinecarboxylic acid (TTCA)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	ProstaglandinsIBA 01/2020
1	Complement C1q (C1q Complement)IBA 07/2019
1	LipopolysaccharidesIBA 01/2019
1	lipoteichoic acidIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2018
1	adriamycinolIBA 07/2015
1	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2015
1	Messenger RNA (mRNA)IBA 06/2012
1	SmokeIBA 06/2012
1	Benzo(a)pyreneIBA 06/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2012
1	Fluorouracil (Carac)FDA LinkGeneric 01/2012
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Gemcitabine FDA Link 01/2012
1	sepantroniumIBA 01/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2012
1	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 01/2012
1	Pharmaceutical PreparationsIBA 01/2012
1	EnzymesIBA 12/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2007
1	Small Interfering RNA (siRNA)IBA 09/2007

Therapy/Procedure

2	Therapeutics 10/2020 - 10/2020
1	Length of Stay 01/2022
1	N95 Respirators 01/2020